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Abstract
Pyruvate dehydrogenase (PDH) plays a key role in the regulation of skeletal muscle sub-
strate utilization. IL-6 is produced in skeletal muscle during exercise in a duration dependent
manner and has been reported to increase whole body fatty acid oxidation, muscle glucose
uptake and decrease PDHa activity in skeletal muscle of fed mice. The aim of the present
study was to examine whether muscle IL-6 contributes to exercise-induced PDH regulation
in skeletal muscle. Skeletal muscle-specific IL-6 knockout (IL-6 MKO) mice and floxed litter-
mate controls (control) completed a single bout of treadmill exercise for 10, 60 or 120 min,
with rested mice of each genotype serving as basal controls. The respiratory exchange ratio
(RER) was overall higher (P<0.05) in IL-6 MKO than control mice during the 120 min of
treadmill exercise, while RER decreased during exercise independent of genotype. AMPK
and ACC phosphorylation also increased with exercise independent of genotype. PDHa
activity was in control mice higher (P<0.05) at 10 and 60 min of exercise than at rest but
remained unchanged in IL-6 MKOmice. In addition, PDHa activity was higher (P<0.05) in
IL-6 MKO than control mice at rest and 60 min of exercise. Neither PDH phosphorylation
nor acetylation could explain the genotype differences in PDHa activity. Together, this pro-
vides evidence that skeletal muscle IL-6 contributes to the regulation of PDH at rest and dur-
ing prolonged exercise and suggests that muscle IL-6 normally dampens carbohydrate
utilization during prolonged exercise via effects on PDH.
Introduction
Skeletal muscle possesses a remarkable ability to regulate substrate use with changing substrate
availability and energy demands [1,2]. As the Randle cycle originally proposed [3], lipids and
carbohydrates (CHO) play competitive but equally essential roles as substrate in energy pro-
duction in muscle. The coordinated dynamic switch between these substrates is vital to sustain-
ing ATP production during prolonged metabolic challenges such as exercise. The demand for
energy supply increases many fold over resting state requirements at the onset of exercise and
PLOSONE | DOI:10.1371/journal.pone.0156460 June 21, 2016 1 / 17
a11111
OPEN ACCESS
Citation: Gudiksen A, Schwartz CL, Bertholdt L,
Joensen E, Knudsen JG, Pilegaard H (2016) Lack of
Skeletal Muscle IL-6 Affects Pyruvate
Dehydrogenase Activity at Rest and during Prolonged
Exercise. PLoS ONE 11(6): e0156460. doi:10.1371/
journal.pone.0156460
Editor: Andrew Philp, University of Birmingham,
UNITED KINGDOM
Received: February 9, 2016
Accepted: May 13, 2016
Published: June 21, 2016
Copyright: © 2016 Gudiksen et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by
Lundbeckfonden: R93-2011-8974, www.
lundbeckfonden.com/; Danish Agency for Science,
Technology and Innovation, DFF-1323-00317, http://
ufm.dk/en/the-minister-and-the-ministry/organisation/
the-danish-agency-for-science-technology-and-
innovation/contact. The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
simultaneous induction of numerous metabolic pathways are initiated across tissues in order
to increase both fat and carbohydrate availability and oxidation [4,5]. During prolonged low to
moderate intensity exercise, a reciprocal shift from CHO to lipid oxidation occurs in skeletal
muscle in order to spare muscle glycogen stores and hence prolong the ability for the muscle to
contract [6,7]. However, the molecular mechanisms behind this remain to be elucidated.
The pyruvate dehydrogenase complex (PDC) represents the only point of entry for CHO
derived fuel into the mitochondria for complete oxidation [8,9] and is therefore seen as a meta-
bolic gatekeeper. Located within the mitochondrial matrix, the PDC exerts its role by catalyzing
the rate-limiting and irreversible decarboxylation of pyruvate thereby connecting glycolysis
with the Krebs cycle. The PDC is composed of multiple copies of the three enzymatic subunits
E1, E2, and E3, where the tetrameric (2α/2β) E1 enzyme, also termed pyruvate dehydrogenase
(PDH), is the initial catalyst in the decarboxylation step (Harris, 2001). Covalent modifications
by means of phosphorylation of at least four different serine sites (site 1: Ser293; site 2: Ser300;
site 3: Ser232, and site 4: Ser295) on the E1 enzyme have so far been thought to be the main reg-
ulatory mechanism controlling the activity of the PDC, although allosteric regulation by the
substrates, pyruvate and NAD+, and the products, acetyl-CoA and NADH, as positive and neg-
ative allosteric effectors, respectively, may also contribute [10–12]. The activity of PDH in its
active form (PDHa activity) is inhibited by phosphorylation catalyzed by 4 isoforms of PDH
kinases (PDK) and stimulated by dephophorylation catalyzed by 2 isoforms of PDH phospha-
tases (PDP), of which PDK2 and PDK4 and the Ca2+-sensitive PDP1 have been suggested to be
the most highly expressed isoforms in skeletal muscle [13,14]. PDHa activity is rapidly
increased within the first minutes of exercise strongly correlated with exercise intensity [15–
17]. In addition, PDHa activity has been shown to decrease after 2h of exercise in humans
[12,18] reflecting a dominant reliance on CHO at the onset of exercise which gradually
decreases over time as FFA available and lipid oxidation increase [7,18,19]. Furthermore, the
exercise-induced regulation of PDHa activity has been shown to be associated with opposite
changes in PDH phosphorylation in human skeletal muscle [19–21] indicating phosphoryla-
tion as an important regulatory mechanism in the regulation of PDH. Moreover, recent studies
have provided evidence for acetylation of PDH-E1α, with the NAD+-dependent deacetylase
sirtuin 3 (SIRT3) shown to target PDH-E1α, possibly playing an important role in maintaining
the tight control of the complex [22,23].
Although the regulation of PDHa activity through post-translational modifications is well
established, the signaling pathways inducing these modifications remain to be fully investi-
gated. Previous studies suggest that interleukin (IL) 6 may play a role. Thus, human studies
have shown that IL-6 is produced in and released from skeletal muscle during exercise in a
duration and intensity dependent manner [24,25]. Furthermore, IL-6 infusion in humans has
been shown to increase skeletal muscle fat oxidation [26], and some studies link IL-6 to aug-
mented glucose uptake during exercise in humans [27,28], although others report no correla-
tion between plasma IL-6 concentrations and glucose uptake in human [29] and mouse muscle
[30]. In addition, injections with physiologically relevant doses of recombinant IL-6 have been
shown to decrease PDHa activity in mouse skeletal muscle during fed conditions [31] and
rodent studies have indicated that IL-6 activates AMP activated protein kinase (AMPK)
[27,32]. Moreover, because lack of AMPKα2 has been shown to enhance PDHa activity in
mouse skeletal muscle [33], a regulatory metabolic axis may exist between IL-6, AMPK, and
PDH during exercise. Taken together, IL-6 seems to be a potential candidate for regulating
skeletal muscle PDH during prolonged exercise.
The purpose of this present study was to test the hypothesis that skeletal muscle IL-6 con-
tributes to the regulation of PDH in mouse skeletal muscle at rest as well as during prolonged
exercise and that this is associated with IL-6 mediated regulation of AMPK.
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Methods
Animals
Male C57BL/6 mice carrying loxP inserts that flanked exon 2 of the IL-6 gene as previously
described [34] were crossbred with C57BL/6 mice carrying the cre recombinase gene under
control of the myogenin promoter generating mice carrying the loxP inserts (floxed), serving
as control mice, and skeletal muscle-specific IL-6 knockouts (IL-6 MKO) as previously shown
[35]. Animals were maintained on a 12:12 light-dark cycle at 22°C with ad libitum access to
water and chow diet (Altromin 1314F, Brogaarden, Lynge, Denmark) and were therefore in a
fed state before the exercise intervention. All experiments were approved by the Danish Animal
Experimental expectorate and complied to the European Convention for the protection of ver-
tebrate animals used for experiments and other scientific purposes (Council of Europe no. 123.
Strasbourg, France 1985).
Endurance test protocol
Mice also included in another study (Knudsen et al., 2015) were used to estimate relative
endurance capacity. Mice performed a graded treadmill test (TSE systems, Bad Hamburg, Ger-
many) at 10 degree incline and an initial speed of 11 m/min for 2 min. This was followed by
gradually increasing the velocity every 12th min to 14, 16, 18, 20, and 22 m/min, after which the
incline was increased by 2 degrees every 12th min until exhaustion. Exhaustion was character-
ized as the point where mice could not be encouraged to run further despite being subjected to
gentle electrical shock and stimulation with compressed air.
Acute exercise procedure
At 3 months of age, mice were housed individually and acclimatized to treadmill running (TSE
Systems, Bad Hamburg, Germany) 10 min, 2 times a day for 5 days with 1 day of rest prior to
the experimental day.
The respiratory exchange ratio (RER) was determined during running (n = 5–7) on tread-
mills connected to a Phenomaster unit (TSE Systems, Bad Hamburg, Germany) at 14 m/min
with a 10° incline for 120 min.
On the day of the main experiment, mice were prompted to run at 14 m/min with a 10°
incline (n = 10) for 10 min, 60 min, or 120 min between 8:00 and 10:30 AM before being eutha-
nized by cervical dislocation. Quadriceps muscles were swiftly removed and snap frozen in liq-
uid nitrogen. Trunk blood was obtained in EDTA containing tubes and plasma was obtained
after centrifugation. Both muscle and plasma were stored at -80°C.
Plasma analyses
Plasma NEFA concentrations were measured colorimetrically using a NEFA-HR (2) kit
according to the manufacturer´s guidelines (WAKO Diagnostics GmbH, Germany). Plasma
IL-6 was measured using a mesoscale v-plex kit according to the manufacturer’s guidelines
(MSD, Rockville, MD, USA). Plasma glucose and lactate were measured fluorometrically as
previously described [36].
Muscle analyses
Muscle glucose, lactate, glucose-6 phosphate and glycogen. Whole quadriceps muscles
were crushed in liquid nitrogen to achieve tissue homogeneity. For measurements of muscle
glucose, lactate, and glucose-6-phosphate (G-6-P) 10-15mg of crushed muscle tissue was
extracted in perchloric acid (PCA) and neutralized to a pH of 7–8.
Lack of Skeletal Muscle IL-6 Affects PDHa Activity at Rest and during Prolonged Exercise
PLOS ONE | DOI:10.1371/journal.pone.0156460 June 21, 2016 3 / 17
Muscle glycogen was determined fluorometrically as glycosyl units after hydrolyzing 10–15
mg wet weight muscle samples by boiling for 2h in HCl (1M) as previously described [36].
HAD and CS activity
The maximal activity of citrate synthase (CS) was measured using a citrate synthase Assay Kit
(Sigma-Aldrich) according to manufacturer’s guidelines and maximal β-hydroxyacyl-CoA
dehydrogenase (HAD) activity was measured as previously described [37].
Immunoblotting
Crushed muscle samples (25-35g) were homogenized in lysis buffer (10% glycerol, 20 mM Na-
pyrophosphate, 150 mMNaCl, 50 mMHEPES, 1% NP-40, 20 mM β-glycerophosphate, 10
mMNaF, 1 mM EDTA, 1 mM EGTA, 20 μg/ml aprotinin, 10 μg/ml leupeptin, 2 mM Na3VO4,
3 mM benzamidine, pH 7.5) using a Tissue Lyser II (Qiagen, Germany). Samples for immuno-
precipitation had deacetylase inhibitors (nicotinamide (1mM) and sodium butyrate (5mM))
added to the lysis buffer. Protein content in each of the samples was determined using the
bicinchoninic acid method (Thermo Fischer Scientific, USA) and content was adjusted with
sample buffer to a concentration of 2μg/μl for STAT3Tyr705 and 1μg/μl for the remaining pro-
teins. Protein phosphorylation and protein levels were determined by SDS-PAGE using hand
casted gels and western blotting. Membranes were incubated in primary antibody for determi-
nation of AMPKα2, PDK4 and PDH-E1α protein, PDH-E1αSer293, PDH-E1αSer300, and
PDH-E1αSer295phosphorylation (all kindly provided by Professor Graham Hardie, University
of Dundee, Scotland), P38 protein, P38Thr180/Tyr182 phosphorylation, Hexokinase (HK) II pro-
tein, AMPKThr172phosphorylation, signal transducer and activator of transcription (STAT3)
protein, STAT3Tyr705 phosphorylation (#9212, #4511, #2867, #2535, #9139, #9138, and #9441,
respectively, Cell Signaling Technologies, Danvers, MA, USA), acetyl CoA carboxylase (ACC)-
Ser212 phosphorylation and PDH-E1αSer232 phosphorylation (07–303 and #AP1063, respec-
tively, EMDMillipore, Bedford, USA), PDK1 and OXPHOS proteins (ab90444 and ab110413,
respectively, Abcam, Cambridge, U.K.), PDK2 protein (ST1643, CalBioChem, Bedford, USA),
PDP1 protein (Sigma-Aldrich, St. Louis, USA) and GLUT4 protein (PAI-1065, ABR, Connecti-
cut, USA). Species-specific horseradish peroxidase conjugated immunoglobulin secondary
antibodies (DAKO, Denmark) were used for incubation the following day (ACC2 was incu-
bated with streptavidin as primary antibody) and protein bands were subsequently visualized
using an ImageQuant LAS 4000 imaging system and quantified with ImageQuant TL 8.1 soft-
ware (GE Healthcare, Freiburg, Germany).
Immunoprecipitation for protein acetylation
A total of 100 μg of protein from lysate was immunoprecipitated for the determination of
PDH acetylation state. Briefly the lysate was added to washed protein G agarose beads (EMD
Millipore, Bedford, USA) in a 50:50 solution with PBS buffer containing 10% Triton X with
2μg of PDH-E1α antibody. The samples were rotated end over end at 4°C overnight and on
the subsequent day the beads were washed, sample buffer was added and the samples were
shortly heated to 96°C for 3 minutes. The beads were spun down and lysate loaded on a hand-
casted gel for SDS-page and western blotting as described above and incubated with total
lysine acetylation antibody (#9441, Cell Signaling Technologies, Danvers, MA, USA). Acety-
lated protein was normalized to the amount of precipitated PDH-E1α protein content for
each sample.
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RNA isolation, reverse transcription, and Real-time PCR
RNA was isolated using a modified guanidium-thiocyanate-chloroform protocol as previously
described [38–40]. Reverse transcription was performed on 3μg of RNA from quadriceps mus-
cle using the Superscript II RNAse H- system and oligodT (Life Technologies, Nærum, Den-
mark). To determine mRNA content, real-time PCR was performed using the ABI-7900
Sequence Detection System (Applied biosystems, Foster City, CA, USA). A fragment of cDNA
was amplified using the following oligo sequences for IL-6: forward 5´GCTTAATTACACAT
GTTCTCTGGGAAA3´, reverse 5´CAAGTGCATCGTTGTTCATAC3´ and Taqman probe
5`ATCAGAATTGCCATTGCACAACTCTTTTCTCAT3´, and for SOCS3: forward 5
´GCCACCTGGACTCCTATGAGAA3´, reverse 5´GAGCATCATACTGATCCAGGAACTC3´, and
Taqman probe 5´TGACCCAGCTGCCTGGAC CCATT3´. Samples were run in triplicates
together with a serial dilution made from a pool of aforementioned samples. The serial dilution
was used to create a standard curve for quantification of the specific amount of mRNA from
obtained sample Ct values. For each sample, the target mRNA content was normalized to β-
actin mRNA, which was not affected by either exercise or genotype.
PDHa activity
PDHa activity (activity of PDH in the active form) was determined after homogenizing 10-
15mg of wet weight muscle tissue and snap-freezing the homogenate in liquid nitrogen as pre-
viously described [15,19,41,42] and normalized to creatine content in each muscle sample.
Statistics
All values are expressed as means ± SE. A two-way ANOVA was used to test the effects of
genotype and exercise. When a main effect was detected a Student-Newmann-Keuls test was
applied as a post-hoc test to locate differences. For single group data, a student’s t-test was used
to test if a difference was present. Significance was accepted at P<0.05 and a tendency for
0.05P0.1. Results were analyzed using Sigmaplot 13.0 (Systat, USA).
Results
Endurance Test
Running duration was shorter (P<0.05) for IL-6 MKOmice than for control mice (Fig 1A).
HK II, GLUT 4, OXPHOS complexes, HAD and CS activity. There were no differences
in basal protein content of HKII and GLUT4 (Fig 1B) or OXPHOS complexes in skeletal mus-
cle of control and IL-6 MKOmice (Fig 1C). Similarly, there were no genotype differences in
basal CS or HAD activity in skeletal muscle (Fig 1D).
Plasma IL-6
Plasma IL-6 was non-detectable at rest and at 10 min of exercise in both control and IL-6 MKO
mice, but increased (P<0.05) in both genotypes after 60 min and 120 min of exercise. IL-6
MKO had higher (P<0.05) plasma IL-6 than control mice after 120 min of exercise (Fig 2A).
IL-6 and SOCS3 mRNA. There was an overall difference (P<0.05) in IL-6 mRNA content
between control and IL-6 MKOmice with ~300% higher (P<0.05) IL-6 mRNA content in con-
trol than IL-6 MKO mice at rest and after 10 min and 60 min of exercise, and ~140% higher
(P<0.05) in control than IL-6 MKOmice after 120 min of exercise (Fig 2B). There was no
effect of exercise on muscle IL-6 mRNA at 10 min and 60 min of exercise, while IL-6 mRNA
content was lower (P<0.05) at 120 min of exercise than rest in control mice. The residual IL-6
mRNAmeasured in the IL-6 MKO mice is assumed to originate from non-muscle tissue.
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SOCS3 mRNA was lower (P<0.05) at 60 min and 120 min of exercise than at rest in both geno-
types with no difference between genotypes at any of the time points (Fig 2C).
STAT3. STAT3Tyr705phosphorylation in muscle was higher (P<0.05) than at rest after 60
min of exercise in control mice and after 120 min in both genotypes (Fig 2D). There was no dif-
ference in STAT3Tyr705phosphorylation and STAT3 protein between the genotypes.
Plasma glucose, NEFA, and lactate. The plasma glucose concentration was higher
(P<0.05) in IL-6 MKO than in control mice at rest. The plasma glucose level was higher
(P<0.05) at 10 min and 60 min of exercise than at rest in control mice, whereas plasma glucose
was lower (P<0.05) after 120 min of exercise than at rest in IL-6 MKOmice (Table 1). While
plasma NEFA concentrations did not change significantly during exercise in control mice, the
plasma NEFA level in IL-6 MKO mice was lower (P<0.05) after 10 and 60 min of exercise and
higher (P<0.05) after 120 min of exercise than at rest. The plasma NEFA was lower (P<0.05)
Fig 1. A Running duration (min) in a graded treadmill endurance test and basal skeletal muscleB)HKII and GLUT4 protein content, C)OXPHOS
complex (I-V) protein content andD) HAD and CS activity in skeletal muscle specific IL-6 knockout (IL-6 MKO) and littermate floxed control (Control)
mice. Protein levels are given in arbitrary units (AU). Values are given as mean ± SE; n = 6–10 in A and n = 9–10 in B-D. #: significantly different from
control, P<0.05;
doi:10.1371/journal.pone.0156460.g001
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in IL-6 MKO than control mice at 10 min of exercise and tended to be higher (0.05P<0.1) in
IL-6 MKO than control mice at 120 min of exercise (Table 1). The plasma lactate concentration
was lower (P<0.05) after 120 min of exercise than at rest in both genotypes. Furthermore, the
plasma lactate concentration was lower (P<0.05) in IL-6 MKO than in control mice at rest and
after 10 min of exercise (Table 1).
Muscle glucose, G-6-P, glycogen, lactate and acetyl CoA
Muscle glucose concentration in control mice was higher (P<0.05) after 10 min and tended to
be higher (0.05P<0.1) after 60 min of treadmill exercise than at rest. Furthermore, muscle
Fig 2. A) Plasma IL-6 and skeletal muscleB) IL-6 mRNA,C) SOCS3mRNA andD) STAT3 Tyr705
phosphorylation in skeletal muscle specific IL-6 knockout (IL-6 MKO) and littermate floxed control (Control)
mice at rest and after 10, 60 or 120 min of exercise. Protein levels are given in arbitrary units (AU). Values are
given as mean ± SE; n = 10. *: significantly different from rest within given genotype, P<0.05. #: significantly
different from control within given time point, P<0.05.
doi:10.1371/journal.pone.0156460.g002
Table 1. Plasma concentrations of glucose, NEFA, and lactate. Plasma glucose, non-esterified fatty acids (NEFA), and lactate in skeletal muscle specific
IL-6 knockout (IL-6 MKO) and littermate floxed controls (Control) mice at rest and after 10, 60 or 120 min of exercise. Values are given as mean ± SE;
n = 9–10.
Rest 10 min 60 min 120 min
Control IL6-MKO Control IL6-MKO Control IL6-MKO Control IL6-MKO
Glucose (mmol/L) 7.29 ±0.25 8.26 ±0.31# 8.45 ±0.20* 8.38 ±0.42 8.79 ±0.35* 8.97 ±0.20 7.56 ±0.53 6.89 ±0.46*
NEFA (mmol/L) 0.86 ±0.09 0.76 ±0.05 0.75 ±0.05 0.57 ±0.03*,# 0.68 ±0.05 0.65 ±0.03* 0.85 ±0.04 0.99 ±0.03*,(#)
Lactate (mmol/L) 6.76 ±0.68 4.64 ±0.36# 6.70 ±0.70 4.21 ±0.29# 5.18 ±0.75 4.50 ±0.63 4.16 ±0.67* 2.44 ±0.33*
*: signiﬁcantly different from rest within given genotype, P<0.05.
#: signiﬁcantly different from control within given time point, P<0.05. (*): Tendency to be signiﬁcantly different from rest within given genotype,
0.05<P<0.01, (#): Tendency to be signiﬁcantly different from control within given time point, P<0.05.
doi:10.1371/journal.pone.0156460.t001
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glucose was higher (P<0.05) in control than in IL-6 MKO mice at both these time points
(Table 2). Muscle G-6-P tended to be lower (0.05P<0.1) after 10 and 60 min of exercise than
at rest in both genotypes. G-6-P in IL-6 MKO mice was lower (P<0.05) after 60 min than at
rest and in both genotypes lower (P<0.05) after 120 minutes of exercise than at rest (Table 2).
Muscle glycogen gradually decreased with exercise (P<0.05) and was different from rest at
every time point without any significant differences between control and IL-6 mice (Table 2).
It may be noted that the difference in muscle glycogen from Rest to 120 min of exercise was
50% less in IL-6 MKO than Control mice, but this difference was not significant. Furthermore,
the muscle lactate concentration was lower (P<0.05) after 120 min of exercise than at rest in
both genotypes (Table 2). Muscle acetyl CoA was not affected by exercise or genotype.
AMPK and ACC
AMPKThr172phosphorylation in IL-6 MKOmice was higher (P<0.05) after 10, 60, and 120
min of exercise than at rest and in control mice higher (P<0.05) after 60 and 120 min than at
rest (Fig 3A). There were no genotype differences in skeletal muscle AMPKThr172phosphoryla-
tion and AMPKα2 protein (Fig 3A). ACCSer212phosphorylation after 10, 60, and 120 min of
Table 2. Skeletal muscle glucose, G-6-P, glycogen, lactate, and acetyl CoA content. Skeletal muscle glucose, glucose -6 phosphate (G-6-P), glycogen,
lactate and acetyl CoA in skeletal muscle specific IL-6 knockout (IL-6 MKO) and littermate floxed controls (Control) mice at rest and after 10, 60 or 120 min of
exercise. Values are given as mean ± SE; n = 9–10.
Rest 10 min 60 min 120 min
Control IL6-MKO Control IL6-MKO Control IL6-MKO Control IL6-MKO
Glucose (mmol/kg) 0.41 ±0.04 0.2 ±0.04 0.66 ±0.08* 0.46 ±0.05# 0.62 ±0.08(*) 0.41 ±0.05# 0.38 ±0.03 0.31 ±0.05
G-6-P (mmol/kg) 5.85 ±0.14 5.86 ±0.19 5.64 ±0.21 5.39 ±0.16(*) 5.31 ±0.11(*) 5.14 ±0.14* 5.08 ±0.18* 4.86 ±0.21*
Glycogen (mmol/kg) 16.25 ±1.1 18.41 ±1.49 12.14 ±0.39* 12.35 ±1.14* 7.87 ±0.84* 10.64 ±0.78* 8.60 ±1.17* 6.93 ±0.78*
Lactate (mmol/kg) 3.83 ±0.29 4.37 ±0.54 3.97 ±0.55 3.88 ±0.19 3.46 ±0.51 3.49 ±0.39 2.85 ±0.48* 2.72 ±0.74*
Acetyl CoA (mmol/kg) 0.952±0.06 0.851±0.05 0.821±0.03 0.865±0.04 0.831±0.03 0.860±0.03 0.905±0.03 0.798±0.03
*: signiﬁcantly different from rest within given genotype, P<0.05.
#: signiﬁcantly different from control within given time point, P<0.05. (*): Tendency to be signiﬁcantly different from rest within given genotype,
0.05<P<0.01. (#): Tendency to be signiﬁcantly different from control within given time point, P<0.05.
doi:10.1371/journal.pone.0156460.t002
Fig 3. A) AMP-activated protein kinase (AMPK) Thr172 phosphorylation andB) Acetyl-CoA carboxylase 2
(ACC2) phosphorylation in skeletal muscle from skeletal muscle specific IL-6 knockout (IL-6 MKO) and
littermate floxed controls (Control) mice at rest and after 10, 60 or 120 min of exercise. Values are given as
mean ± SE; n = 9–10. Phosphorylation levels are given in arbitrary units (AU). *: significantly different from
rest within given genotype, P<0.05. #: significantly different from control within given time point, P<0.05. (*):
Tendency to be significantly different from rest within given genotype, 0.05<P<0.01.
doi:10.1371/journal.pone.0156460.g003
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exercise was higher (P<0.05), apart fromMKOmice having a tendency to be higher (0.5 P
0.1) at 60 min (P = 0.078), than at rest in both genotypes (Fig 3B). There were no genotype
differences in skeletal muscle ACCSer212phosphorylation and ACC2 protein (Fig 3B).
PDH-E1α phosphorylation, PDK and PDP protein
While skeletal muscle PDH-E1αSer293 and PDH-E1αSer295 phosphorylation (site 1 and 4) did
not change during the 120 min of treadmill exercise, PDH-E1αSer300 and PDH-E1αSer232pho-
sphorylation (site 2 and 3) was lower (P<0.05) after 10 and 60 min of exercise than at rest in
both control and IL-MKOmice (Fig 4A and 4B). There were no differences in skeletal muscle
PDK1, PDK2, PDK4 or PDP1 protein content between time points or genotypes (Fig 4D).
PDH acetylation and SIRT3
There were no differences in skeletal muscle SIRT3 or PDH-E1α acetylation (Fig 4C).
PDHa activity
PDHa activity was higher (P<0.05) after 10 and 60 min of exercise than at rest in control mice,
while there was no effect of exercise on PDHa activity in IL-6 MKOmice. The PDHa activity
was higher (P<0.05) in IL-6 MKO than control mice at rest and 60 min of exercise (Fig 5).
There were no differences in skeletal muscle PDH-E1α protein.
Indirect calorimetry
RER was lower (P<0.05) after 120 min than after 10 min of exercise in both genotypes. Fur-
thermore, IL-6 MKOmice displayed an overall higher (P<0.05) RER than control mice during
the 120 min of treadmill exercise (Fig 6).
Fig 4. A) PDH Ser300 phosphorylation, B) PDH Ser232 phosphorylation, C) PDH acetylation in skeletal
muscle from skeletal muscle specific IL-6 knockout (IL-6 MKO) and littermate floxed controls (Control) at rest
and after 10, 60 or 120 min of exercise and D) basal PDK1, PDK2, PDK4 and PDP1. Values are given as
mean ± SE; n = 10 in A,B and D and n = 5 in C. *: significantly different from rest within given genotype,
P<0.05. #: significantly different from control within given time point, P<0.05.
doi:10.1371/journal.pone.0156460.g004
Lack of Skeletal Muscle IL-6 Affects PDHa Activity at Rest and during Prolonged Exercise
PLOS ONE | DOI:10.1371/journal.pone.0156460 June 21, 2016 9 / 17
Fig 5. PDHa activity in skeletal muscle from skeletal muscle specific IL-6 knockout (IL-6 MKO) and
littermate floxed controls (Control) at rest and after 10, 60 or 120 min of exercise. Values are given as
mean ± SE; n = 10. *: significantly different from rest within given genotype, P<0.05. #: significantly different
from control within given time point, P<0.05.
doi:10.1371/journal.pone.0156460.g005
Fig 6. Respiratory Exchange Ratio (RER) in skeletal muscle specific IL-6 knockout (IL-6 MKO) and
littermate floxed controls (Control) during 120min of metabolic treadmill exercise. Values are given as
mean ± SE for every 10 minutes of continuous measurements; n = 5–7. *: significantly different from 10 min
within given genotype, P<0.05. #: significantly different from control within given time point, P<0.05.
doi:10.1371/journal.pone.0156460.g006
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Western blots
For all representative western blots consult Fig 7.
Discussion
The main findings of the present study are that lack of skeletal muscle IL-6 led to elevated
PDHa activity at rest and during exercise without changes in PDHa activity during prolonged
exercise as observed in control mice. In addition, IL-6 MKO mice had an overall higher RER
during exercise than controls, but maintained the ability to reduce RER during prolonged exer-
cise. Together this indicates that muscle IL-6 influences substrate utilization in skeletal muscle
through effects on PDH, but is not required for the shift in substrate use during prolonged
exercise.
The observations that the exercise bout in the present study was associated with a gradual
decrease in RER and a transient increase in skeletal muscle PDHa activity in control mice as
previously reported in humans [7,18,19]), suggest that the experimental setup provides the
basis for studying the impact of muscle IL-6 on exercise-induced PDH regulation in skeletal
muscle and substrate utilization.
The present findings that IL-6 MKO mice had higher skeletal muscle PDHa activity at rest
and after 1h of exercise and did not exhibit a significant change in PDHa activity during exer-
cise show for the first time that lack of skeletal muscle IL-6 affects the regulation of PDH in
skeletal muscle. It should be noted that this suggestion is possible although PDHa activity
was not significantly different between the genotypes at 2 h of exercise, because the plasma
IL-6 levels were increased in both genotypes at 2 h of exercise. Thus, PDHa activity may have
been influenced by IL-6 derived from other tissues than skeletal muscle late during exercise.
It cannot be excluded that the lack of change in PDHa activity in response to exercise in IL-6
MKO mice is due to PDHa activity being close to full activation already at rest and that a
change therefore was not detected during exercise in the present study. However, we have
previously observed ~25% higher levels of PDHa activity in mice running at a higher speed
and treadmill slope than in the present study (unpublished results). In addition, the observed
muscle IL-6 dependent regulation of PDHa activity is in accordance with a previous mouse
study showing that a single injection of recombinant IL-6 altered PDHa activity in skeletal
Fig 7. Representative blots of STAT3, STAT3 Tyr705 phosphorylation (phos), AMPK Thr 172 phos,
AMPKα2, ACC2 Ser212 phos, ACC2, PDH Ser293 phos, PDH Ser300 phos, PDH Ser232 phos, PDH
Ser295 phos, PDH protein, lysine acetylated pdh-E1α protein, sirtuin 3 (SIRT3), Hexokinase II (HKII),
GLUT4, OXPHOS complexes I-V, PDK1, PDK2, PDK4 and PDP1 protein content.
doi:10.1371/journal.pone.0156460.g007
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muscle, although the change was dependent on the nutritional state as IL-6 lowered PDHa
activity in the fed state and increased PDHa activity in the fasted state [31]. Furthermore, the
observed impact of muscle-specific IL-6 knockout on PDHa activity suggests that muscle IL-
6 normally exerts an inhibitory effect on skeletal muscle PDH with a concomitant decrease in
carbohydrate oxidation. Although differences in PDHa activity do not necessarily relate to
flux and may therefore not be linked to the difference in RER between IL-6 MKO and control
mice, the observed higher RER in IL-6 MKO mice than controls during the exercise bout
does support that IL-6 reduces carbohydrate oxidation. On the other hand, the maintained
ability of the IL-6 MKO mice to reduce RER during the exercise bout indicates opposite of
the hypothesis that muscle IL-6 is not required for a switch towards fat oxidation during pro-
longed exercise in mice. However, the increase in circulating IL-6 in IL-6 MKO mice is in
accordance with a potential effect of non-muscle-derived IL-6 on substrate utilization and
hence RER during prolonged exercise. In addition, the higher PDHa activity in IL-6 MKO
than control mice not only during exercise, but also at rest emphasizes that muscle IL-6 may
not only function as a contraction-induced myokine, but also regulates basal skeletal muscle
metabolism.
To elucidate the mechanistic regulatory pattern behind the different regulation of PDHa
activity when muscle IL-6 is lacking, the four known PDH phosphorylation sites, site 1: Ser293;
site 2: Ser300; site 3: Ser232, and site 4: Ser295, were examined. The observation that phosphor-
ylation of Both sites 2 and 3 followed an overall inverse pattern of the PDHa activity in control
mice with robust decreases in absolute phosphorylation during exercise is in accordance with
previous findings for site 1 and 2 in humans [19–21]. Moreover, the similar resting and exer-
cise-induced changes in site 2 and 3 and similar lack of change in site 1 and 4 phosphorylation
in IL-6 MKO and control mice indicates that diverse regulation of PDH phosphorylation is not
the main underlying mechanism for the observed genotype differences in PDHa activity in the
present study. In addition, the lack of difference in PDK1, PDK 2, PDK4 and PDP1 protein
during exercise in either genotype suggests that protein content does not account for the
observed PDH phosphorylation response. Due to the complex site-specific affinity patterns of
the various PDKs [43] measuring the activities of all PDK isoforms may likely be needed to
fully understand the exercise-induced regulation of PDH phosphorylation and PDHa activity.
As it recently has been reported that the mitochondrial NAD+ dependent deacetylase, SIRT3,
targets the PDH-E1α subunit in C2C12 cells [22], the acetylation state in skeletal muscle at rest
and during exercise might reveal the mechanism explaining the observed changes in PDHa
activity with lack of skeletal muscle IL-6. However, the observation that total lysine acetylation
of immunoprecipitated PDH-E1α was similar in IL-6 MKO and control mice does not support
that acetylation is regulated by skeletal muscle IL-6, although it cannot be excluded that the
total acetylation pattern disguises more subtle differences in acetylation that may be more sig-
nificant to regulation, but this remains to be determined.
As IL-6 has previously been reported to increase AMPK activity both in human [27] and
mouse tissue [31,32] and AMPK has been suggested to regulate PDH [33,44], it was hypothe-
sized that AMPK mediates the effects of IL-6 on PDHa activity and substrate utilization. How-
ever, the similar exercise-induced AMPK phosphorylation in IL-6 MKO and control mice does
not support IL-6 mediated regulation of AMPK as previously reported, although it might be
speculated that IL-6-induced regulation of AMPK is overshadowed by stronger effectors in an
acute exercise setting.
The finding that plasma glucose at rest was higher in the IL-6 MKO than control mice and
the plasma glucose did not drop significantly until the latter stages of the exercise bout might
reflect lower glucose removal by skeletal muscle in IL-6 MKOmice or be due to higher hepatic
glucose output in IL-6 MKO than in control mice. Furthermore, the observation that basal
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hexokinase and GLUT4 protein content as well as G-6-P concentrations in skeletal muscle
were similar in the two genotypes, while muscle glucose was lower in the IL-6 MKO than con-
trol mice may advocate more for a higher glycolytic flux and carbohydrate utilization in mice
lacking skeletal muscle IL-6 rather than a lower glucose uptake. In addition, the genotype dif-
ference in running endurance during an incremental exercise running test may suggest that
the IL-MKOmice were running at a higher relative intensity than the control mice in the cur-
rent exercise study. However, the IL-6 MKOmice did not require more motivation than the
controls during the 2 hour moderate intensity exercise protocol and completed the protocol as
the controls in the present study. Furthermore, as a previous human study has reported inten-
sity dependent AMPK regulation [45], the similar exercise-induced AMPK and ACC phos-
phorylation in the two genotypes in the present study suggests that the relative exercise
intensity was equal in the IL-6 MKO and control mice during the exercise bout, which is fur-
ther supported by the identical decrease in muscle glycogen in the two genotypes during
exercise.
The observation that the plasma IL-6 concentrations were significantly elevated after 2
hours of running in control mice is in accordance with previous murine studies [46,47]. The
finding that plasma IL-6 concentrations in the control mice reached rather modest levels of
~15 pg/ml points towards the possibility that the loxP inserts in the floxed control mice might
affect expression or release of IL-6. Hence, other studies with various treadmill protocols have
reported increases in circulating plasma IL-6 to levels between 40–70 pg/ml [30,48]. The obser-
vation that skeletal muscle IL-6 mRNA did not increase with the 2 hours of treadmill exercise
and even decreased at the end of the exercise bout, opposes previous findings [49], and suggests
that exercise did not induce IL-6 transcription in skeletal muscle of the floxed IL-6 mice. It can-
not be excluded that exercise may have increased IL-6 mRNA in other muscles thean the inves-
tigated quadriceps, but regardless, the skeletal muscle IL-6 mRNA data show that IL-6 was
knocked out, which was also confirmed at the level of DNA (S1 Fig). Therefore, the exercise-
induced increase in circulating IL-6 levels in the IL-6 MKOmice cannot be originating from
skeletal muscle fibers and based on previous findings [50] suggests that IL-6 derived from adi-
pose tissue may be responsible for the increase in plasma IL-6 during exercise in the present
experiment. This may indicate that the observed skeletal muscle IL-6 dependent effects on skel-
etal muscle PDHa activity are mediated by autocrine/paracrine effects of IL-6. However, the
identical exercise-induced STAT3 phosphorylation and identical decline in SOCS3 mRNA in
the two genotypes suggest that signaling pathways traditionally accredited to be induced by IL-
6 were affected similarly by exercise in the two genotypes. Thus, the observed metabolic differ-
ences must be exerted through other pathways. In addition, a variety of other cytokines and
hormones have been reported to trigger the STAT3 signaling pathway [51,52] and any of these,
or non-muscle derived IL-6 may be responsible for the observed STAT3 pathway inductions
and explain why this response was also present in IL-6 MKO mice.
The current observation that IL-6 MKOmice displayed a lower exercise capacity than the
control mice when submitted to an incremental endurance exercise test is consistent with some
[53], but not all previous observations in IL-6 whole body knockout mice [30,54]. The findings
that skeletal muscle CS and HAD activities as well as the content of OXPHOS proteins were
similar in the two genotypes indicate that skeletal muscle oxidative capacity was unaffected by
the lack of skeletal muscle IL-6. Together with the observed higher RER value during exercise
in IL-6 MKOmice than controls in the present study this may suggest that the reduced exercise
endurance in the IL-6 MKOmice is due to increased carbohydrate/reduced fat utilization rela-
tive to controls rather than reduced skeletal muscle oxidative capacity.
In conclusion, the present findings show, for the first time, that lack of skeletal muscle IL-6
leads to elevated PDHa activity in skeletal muscle both at rest and during exercise, and
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prevented significant changes in PDHa activity during prolonged exercise. Differences in PDH
phosphorylation did not seem to explain these genotype differences in PDHa activity and the
mechanisms behind are still elusive. In addition, lack of skeletal muscle IL-6 resulted in higher
RER during prolonged exercise suggesting that IL-6 normally reduce carbohydrate oxidation
during exercise via effects on skeletal muscle PDH.
Supporting Information
S1 Fig. Representative PCR gel of products generated with primers surrounding exon 2 of
the IL-6 gene in quadriceps muscle from floxed and IL-6 skeletal muscle-specific knockout
mice. A reduction in band size from 1,000 bp to 260 bp in is equal to the loss of exon 2 of the
IL-6 gene. WT Ctrl: Wild-type control, Flox Ctrl: Floxed control, MKO Control: Skeletal mus-
cle-specific knockout Control.
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